These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34293856)

  • 1. Potent Phenylpyridine and Oxodihydrofuran Inhibitors of Cyclooxygenase-2: Optimization toward a Long Residence Time with Balanced Internal Energetics.
    Tian G; Suarez J; Zhang Z; Connolly P; Ahn K
    Biochemistry; 2021 Aug; 60(31):2407-2418. PubMed ID: 34293856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer.
    Zhang Z; Ghosh A; Connolly PJ; King P; Wilde T; Wang J; Dong Y; Li X; Liao D; Chen H; Tian G; Suarez J; Bonnette WG; Pande V; Diloreto KA; Shi Y; Patel S; Pietrak B; Szewczuk L; Sensenhauser C; Dallas S; Edwards JP; Bachman KE; Evans DC
    J Med Chem; 2021 Aug; 64(15):11570-11596. PubMed ID: 34279934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Alsayed SS; Elshemy HA; Abdelgawad MA; Abdel-Latif MS; Abdellatif KR
    Bioorg Chem; 2017 Feb; 70():173-183. PubMed ID: 28057325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme.
    Mohamed LW; Shaaban MA; Zaher AF; Alhamaky SM; Elsahar AM
    Bioorg Chem; 2019 Mar; 83():47-54. PubMed ID: 30342385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY.
    Abdelall EKA; Lamie PF; Ali WAM
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and discovery of pyrazolo-pyridine analogs as inflammation medications through pro- and anti-inflammatory cytokine and COX-2 inhibition assessments.
    Dennis Bilavendran J; Manikandan A; Thangarasu P; Sivakumar K
    Bioorg Chem; 2020 Jan; 94():103484. PubMed ID: 31796215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.
    Riendeau D; Percival MD; Brideau C; Charleson S; Dubé D; Ethier D; Falgueyret JP; Friesen RW; Gordon R; Greig G; Guay J; Mancini J; Ouellet M; Wong E; Xu L; Boyce S; Visco D; Girard Y; Prasit P; Zamboni R; Rodger IW; Gresser M; Ford-Hutchinson AW; Young RN; Chan CC
    J Pharmacol Exp Ther; 2001 Feb; 296(2):558-66. PubMed ID: 11160644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new thiazolo-celecoxib analogues as dual cyclooxygenase-2/15-lipoxygenase inhibitors: Determination of regio-specific different pyrazole cyclization by 2D NMR.
    Abdelall EK; Kamel GM
    Eur J Med Chem; 2016 Aug; 118():250-8. PubMed ID: 27131067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors.
    Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC
    Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
    Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed.
    Liu R; Xu KP; Tan GS
    Eur J Pharmacol; 2015 Dec; 769():127-33. PubMed ID: 26548623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic basis for selective inhibition of cyclo-oxygenases.
    Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
    Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
    Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
    Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
    BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First and second generations of COX-2 selective inhibitors.
    de Leval X; Julémont F; Benoit V; Frederich M; Pirotte B; Dogné JM
    Mini Rev Med Chem; 2004 Aug; 4(6):597-601. PubMed ID: 15279593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ click chemistry generation of cyclooxygenase-2 inhibitors.
    Bhardwaj A; Kaur J; Wuest M; Wuest F
    Nat Commun; 2017 Feb; 8(1):1. PubMed ID: 28232747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies.
    Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
    Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
    Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
    J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
    Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
    J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.